Literature DB >> 1439845

Amyloidosis.

G Husby1.   

Abstract

Amyloidosis is a heterogenous group of diseases characterized by deposition of a fibrillar, proteinaceous material, amyloid, in various tissues and organs. Increasing knowledge about the different proteins that constitute the amyloid fibrils has made it possible to classify amyloidosis by the fibril protein, which appears more rational than the traditional classification by its clinical expression. A serum protein is the precursor of the amyloid fibril protein in the various systemic forms of amyloidosis. Although the chemical composition of amyloid is presently well known, the pathogenetic processes that convert such proteins into a fibrillar form and lay them down in the tissues are far from clarified. This review describes the amyloid deposits, some putative pathogenetic mechanisms, and the clinical, therapeutic, and prognostic aspects of the most important forms of amyloid disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439845     DOI: 10.1016/0049-0172(92)90001-t

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

1.  Inhibition of fibrocyte differentiation by serum amyloid P.

Authors:  Darrell Pilling; Christopher D Buckley; Mike Salmon; Richard H Gomer
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation?

Authors:  S Xu; B Bevis; M F Arnsdorf
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

3.  Retrospective molecular detection of Transthyretin Met 111 mutation in a Danish kindred with familial amyloid cardiomyopathy, using DNA from formalin-fixed and paraffin-embedded tissues.

Authors:  B Y Nordvåg; I Ranløv; H M Riise; G Husby; M R el-Gewely
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

4.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

5.  Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients.

Authors:  Senol Kobak; Fahrettin Oksel; Yasemin Kabasakal; Eker Doganavsargil
Journal:  Clin Rheumatol       Date:  2007-07-05       Impact factor: 2.980

6.  Primary systemic amyloidosis and the gastrointestinal tract.

Authors:  D G Fogarty; R J McFarland
Journal:  Ulster Med J       Date:  1995-10

7.  Amyloid Arthropathy of the Hip Joint Associated with Multiple Myeloma: A Case Report.

Authors:  Yoon Je Cho; Young Soo Chun; Kee Hyung Rhyu; Yong Koo Park; Kyung Nam Ryu; Ji Seon Park; Huo Liang; Gwang Young Jung; Won Ju Shin
Journal:  Hip Pelvis       Date:  2016-06-30

8.  Gastric outlet obstruction due to gastric amyloidosis mimicking malignancy in a patient with ankylosing spondylitis.

Authors:  Choon Sik Seon; Young Sook Park; Yu Min Jung; Jeong Ho Choi; Byoung Kwan Son; Sang Bong Ahn; Seong Hwan Kim; Yun Ju Jo
Journal:  Clin Endosc       Date:  2013-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.